Evan Floden tells us about the risk of starting Seqera Labs, the opportunities in sequencing and the challenge of growing into a CEO role.
Read more: Life sciences is ‘going through rapid change’ – opening a software opportunity
Evan Floden tells us about the risk of starting Seqera Labs, the opportunities in sequencing and the challenge of growing into a CEO role.
Read more: Life sciences is ‘going through rapid change’ – opening a software opportunity
